GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Genomtec SA (WAR:GMT) » Definitions » Additional Paid-In Capital

Genomtec (WAR:GMT) Additional Paid-In Capital : zł32.97 Mil(As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Genomtec Additional Paid-In Capital?


Genomtec's quarterly additional paid-in capital declined from Jun. 2023 (zł32.98 Mil) to Sep. 2023 (zł32.97 Mil) but then stayed the same from Sep. 2023 (zł32.97 Mil) to Dec. 2023 (zł32.97 Mil).

Genomtec's annual additional paid-in capital increased from Dec. 2021 (zł9.75 Mil) to Dec. 2022 (zł16.86 Mil) and increased from Dec. 2022 (zł16.86 Mil) to Dec. 2023 (zł32.97 Mil).

Genomtec Additional Paid-In Capital Historical Data

The historical data trend for Genomtec's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomtec Additional Paid-In Capital Chart

Genomtec Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 3.22 9.75 9.75 16.86 32.97

Genomtec Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.86 20.75 32.98 32.97 32.97

Genomtec Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Genomtec Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Genomtec's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomtec (WAR:GMT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Genomtec SA (WAR:GMT) » Definitions » Additional Paid-In Capital
Comparable Companies
WAR:SDS WAR:ICE WAR:INM WAR:CMI WAR:NST WAR:MDG WAR:GMZ WAR:ADV WAR:MTN WAR:MSM ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
4VI:Germany
Address
ul. Stab?owicka 147, PORT Building 2, Wroclaw, POL, 54-066
Website
http://www.genomtec.com
Genomtec SA is an innovative technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.

Genomtec (WAR:GMT) Headlines

No Headlines